title: Hodgkin's disease as a second malignant neoplasm in childhood: report of a case and review of the literature.
abstract: There is a known association between lymphoid malignancy and Hodgkin's disease (HD), but the development of HD in children who have been treated for leukemia or lymphoma is very uncommon. Hodgkin's disease is, after retinoblastoma, the most common primary tumor that is associated with development of second malignant neoplasm. For reasons that remain to be determined, HD is very rare as a second malignancy [1, 2, 3]. We report the case of a eight-year-old girl who developed HD 6 years after treatment for common acute lymphoblastic leukemia (ALL). This case prompted us to review the published literature for cases of secondary HD in childhood. Our experience suggests that we should follow strictly our patients with ALL and be ready to intervene with invasive diagnostic procedures at the least suspicion of a second or recurrent neoplasm. The most frequent causes of second tumors are radiotherapy, genetic susceptibility and prior treatment with certain chemotherapeutic agents, such as nitrogen mustards. It is likely that any type of immunodeficiency, even without symptoms, might play a role in the development of second tumors in childhood.
authors.affiliation: Department of Pediatric Hematology and Oncology, University of Catania, Via Santa Sofia, 78 95123, Catania, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Ragusa
authors.forename: S
authors.initials: S
authors.lastname: Russo
authors.forename: L
authors.initials: L
authors.lastname: Villari
authors.forename: G
authors.initials: G
authors.lastname: Schilirò
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D018572:Disease-Free Survival; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D007223:Infant; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000209:etiology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D015899:Tomography, Emission-Computed, Single-Photon